Literature DB >> 11303542

A survey of subjects with present or previous atrial fibrillation in a Swedish community.

P E Wändell1.   

Abstract

OBJECTIVE: A study of subjects with known atrial fibrillation (AF) in a Swedish community.
DESIGN: A survey of subjects with present, or previous, AF (at 30 September 1998) identified through medical records.
SETTING: A community in the Stockholm Metropolitan area.
RESULTS: Altogether 230 subjects, mean age 73 years, with a history of AF were identified (140 men and 90 women). One-hundred-and-forty-nine patients were identified as having chronic, irreversible AF (65%). Of those with chronic AF, heart failure was noted in 53%, a valvular disease in 8%, hypertension in 32%, coronary heart disease in 36%, diabetes in 17% and an earlier ischaemic cerebrovascular episode in 30%. Hypertension was found as a significant factor for earlier ischaemic cerebrovascular episodes (OR 2.45, 95% CI 1.20-5.19). Anticoagulant treatment was prescribed in 32% out of those with chronic AF. The estimated overall occurrence of subjects with present, or a history of, AF was 0.7% in the community and 1.4% when standardising by age and sex to the whole Swedish population.
CONCLUSION: AF is a common arrhythmia in Sweden, with an estimated occurrence of 1-1.5%, but despite a high rate of ischaemic cerebrovascular events in chronic AF (30%) a low prescription of anticoagulants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11303542

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  6 in total

1.  Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study.

Authors:  Per Wändell; Axel C Carlsson; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Eur J Clin Pharmacol       Date:  2012-09-19       Impact factor: 2.953

2.  Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007.

Authors:  Axel C Carlsson; Per Wändell; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Eur J Clin Pharmacol       Date:  2012-06-10       Impact factor: 2.953

3.  Gender differences in patients with atrial fibrillation.

Authors:  Ralph F Bosch; David Pittrow; Anne Beltzer; Irmtraut Kruck; Wilhelm Kirch; Annette Kohlhaussen; Hendrik Bonnemeier
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-08-27

4.  Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry.

Authors:  Thomas Meinertz; Wilhelm Kirch; Ludger Rosin; David Pittrow; Stefan N Willich; Paulus Kirchhof
Journal:  Clin Res Cardiol       Date:  2011-05-01       Impact factor: 5.460

5.  The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden.

Authors:  Ingela Björholt; Stina Andersson; Gunnar H Nilsson; Ingvar Krakau
Journal:  BMC Fam Pract       Date:  2007-02-26       Impact factor: 2.497

6.  Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.

Authors:  Gunnar H Nilsson; Ingela Björholt
Journal:  BMC Clin Pharmacol       Date:  2004-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.